Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
Martee L. Hensley, John A. Blessing, Robert Mannel, Peter G. RoseVolume:
109
Year:
2008
Language:
english
Pages:
6
DOI:
10.1016/j.ygyno.2008.03.010
File:
PDF, 182 KB
english, 2008